0000914190-19-000279.txt : 20190813 0000914190-19-000279.hdr.sgml : 20190813 20190813170851 ACCESSION NUMBER: 0000914190-19-000279 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190809 FILED AS OF DATE: 20190813 DATE AS OF CHANGE: 20190813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Points Jeffrey S. CENTRAL INDEX KEY: 0001731414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 191021651 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-08-09 0001180145 Cardiovascular Systems Inc CSII 0001731414 Points Jeffrey S. 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 Chief Financial Officer Common Stock 2019-08-09 4 A 0 4251 0 A 44900 D Common Stock 2019-08-09 4 A 0 12752 0 A 57652 D Restrictions lapse as to 1,417 shares on each of 8/13/20, 8/13/21 and 8/13/22. Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2020, 2021 and 2022 versus the Company's peer group. /s/ Amanda Lorentz as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed. 2019-08-13